Cargando…

Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer

BACKGROUND: microRNAs (miRNAs) and N6‐methyladenosine (m(6)A) play important roles in ovarian cancer (OvCa). However, the mechanisms by which miRNAs regulate m(6)A in OvCa have not been elucidated so far. METHODS: To screen m(6)A‐related miRNAs, Pearson's correlation analysis of miRNAs and m(6)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qiulei, Li, Guoqing, Gong, Lanqing, Cai, Jing, Chen, Le, Xu, Xiaohan, Liu, Xiaoli, Zhao, Jing, Zeng, Ya, Gao, Rui, Yu, Lili, Wang, Zehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972042/ https://www.ncbi.nlm.nih.gov/pubmed/36259156 http://dx.doi.org/10.1002/cam4.5246

Ejemplares similares

FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer
por: Li, Guoqing, et al.
Publicado: (2021)

Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p
por: Cai, Jing, et al.
Publicado: (2021)

Omental cancer‐associated fibroblast‐derived exosomes with low microRNA‐29c‐3p promote ovarian cancer peritoneal metastasis
por: Han, Qing, et al.
Publicado: (2023)

Epitranscriptomic Reader HNRNPA2B1 Confers Endocrine Resistance to Breast Cancer Cells
por: Klinge, Carolyn M, et al.
Publicado: (2021)

Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2017)

m(6)A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease
por: Liu, Rui, et al.
Publicado: (2022)

miR-134: A Human Cancer Suppressor?
por: Pan, Jing-Yu, et al.
Publicado: (2017)

Compensatory expression regulation of highly homologous proteins HNRNPA1 and HNRNPA2
por: CHANG, Yan, et al.
Publicado: (2021)

SUN-009 N(6)-Methyladenosine Reader HNRNPA2B1 Regulates Tamoxifen-Sensitivity in Breast Cancer Cells
por: Klinge, Carolyn, et al.
Publicado: (2019)

HNRNPA2B1, as a m(6)A Reader, Promotes Tumorigenesis and Metastasis of Oral Squamous Cell Carcinoma
por: Zhu, Feiya, et al.
Publicado: (2021)

HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster
por: Li, Kexin, et al.
Publicado: (2021)

Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2023)

LncRNA miR205HG hinders HNRNPA0 translation: anti‐oncogenic effects in esophageal carcinoma
por: Dong, Xiaoying, et al.
Publicado: (2021)

m(6)A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1
por: Guo, Huimin, et al.
Publicado: (2020)

Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer
por: Cao, Jian, et al.
Publicado: (2023)

miR-128 Restriction of LINE-1 (L1) Retrotransposition Is Dependent on Targeting hnRNPA1 mRNA
por: Fung, Lianna, et al.
Publicado: (2019)

Tumor cell-fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer
por: Han, Qing, et al.
Publicado: (2019)

Analysis of the inhibitory effects of miR-124 and miR-152 on human epithelial ovarian cancer xenografts in a nude mouse model
por: Liu, Weiwei, et al.
Publicado: (2019)

Activation of the HNRNPA2B1/miR-93-5p/FRMD6 axis facilitates prostate cancer progression in an m6A-dependent manner
por: Sun, Menghao, et al.
Publicado: (2023)

Exosomal Transfer of miR-185 Is Controlled by hnRNPA2B1 and Impairs Re-endothelialization After Vascular Injury
por: Si, Yi, et al.
Publicado: (2021)

lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer
por: Luo, Jun, et al.
Publicado: (2021)

Mutations in Hnrnpa1 cause congenital heart defects
por: Yu, Zhe, et al.
Publicado: (2018)

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma
por: Sestito, Rosanna, et al.
Publicado: (2015)

RP11‐81H3.2 promotes gastric cancer progression through miR‐339‐HNRNPA1 interaction network
por: Chen, Fen‐Rong, et al.
Publicado: (2020)

CircRNA circTIAM1 promotes papillary thyroid cancer progression through the miR-646/HNRNPA1 signaling pathway
por: Zhang, Deguang, et al.
Publicado: (2022)

Abnormal expression of HNRNPA3 in multistep hepatocarcinogenesis
por: Ren, Xinlu, et al.
Publicado: (2021)

Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation
por: Clarke, Joseph-Patrick W. E., et al.
Publicado: (2021)

The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer
por: Guo, Li-Hua, et al.
Publicado: (2013)

MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells
por: Chai, Li, et al.
Publicado: (2018)

hnRNPA2B1-Mediated Extracellular Vesicles Sorting of miR-122-5p Potentially Promotes Lung Cancer Progression
por: Li, Chuang, et al.
Publicado: (2021)

Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis
por: Liu, Bo, et al.
Publicado: (2021)

miR-30c promotes Schwann cell remyelination following peripheral nerve injury
por: Yi, Sheng, et al.
Publicado: (2017)

miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
por: Cao, Shujun, et al.
Publicado: (2021)

Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R
por: Li, Jieyan, et al.
Publicado: (2022)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2014)

miR-133: A Suppressor of Cardiac Remodeling?
por: Li, Ning, et al.
Publicado: (2018)

Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer
por: Lu, Weijia, et al.
Publicado: (2020)

miR-381 functions as a tumor suppressor by targeting ETS1 in pancreatic cancer
por: Qiao, Guanen, et al.
Publicado: (2019)

miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
por: Pang, Xiaoli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c1v0u63klv4chvhrudc8444a71